S. Perez-Vilar

发表

Guillain-Barré Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018-2019 Season.

S. Anderson, E. Woo, R. Forshee, 2020, The Journal of infectious diseases.

Surveillance for Guillain-Barré syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.

R. Forshee, T. MaCurdy, H. Izurieta, 2019, Vaccine.

A simulation study of the statistical power and signaling characteristics of an early season sequential test for influenza vaccine safety

S. Anderson, R. Forshee, T. MaCurdy, 2019, Pharmacoepidemiology and drug safety.

Surveillance for Guillain-Barré syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017-2018 season.

R. Forshee, T. MaCurdy, J. Kelman, 2019, Vaccine.

Operational lessons learned in conducting a multi-country collaboration for vaccine safety signal verification and hypothesis testing: The global vaccine safety multi country collaboration initiative.

M. Sturkenboom, S. Black, D. Weibel, 2018, Vaccine.

Building capacity for active surveillance of vaccine adverse events in the Americas: A hospital-based multi-country network.

M. Sturkenboom, S. Black, S. Perez-Vilar, 2018, Vaccine.

Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: A feasibility assessment.

S. Anderson, P. Mangtani, H. Devlieger, 2018, Vaccine.

Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination.

M. Sturkenboom, S. Black, M. D. de Ridder, 2018, Vaccine.

[Adverse reactions to human papillomavirus vaccine in the Valencian Community (2007-2011)].

J. Tuells, J. Díez-Domingo, S. Perez-Vilar, 2014, Anales de pediatria.

Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021.

G. D. Dal Pan, M. Bradley, S. Perez-Vilar, 2022, JAMA.

Intussusception following rotavirus vaccination in the Valencia Region, Spain

R. Gil-Prieto, J. Díez-Domingo, J. Puig-Barberá, 2015, Human vaccines & immunotherapeutics.

Systematic review of risk of SARS-CoV-2 infection and severity of COVID-19 with therapies approved to treat multiple sclerosis

A. Mosholder, S. Perez-Vilar, Kira Leishear, 2022, Neurological Sciences.

Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients.

Maria E. Kempner, C. Steiner, R. Hubbard, 2022, JAMA.

Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines – Multi-country assessment

B. Carleton, M. Sturkenboom, S. Overeem, 2018, Vaccine.

Prevalence of oral human papillomavirus infection among university students in Valencia, Spain.

J. Díez-Domingo, S. Perez-Vilar, J. J. Vilata-Corell, 2019, Vaccine.

Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectiveness

K. Bollaerts, N. Andrews, D. Macina, 2018, PloS one.

Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017.

G. Dores, P. Haber, John R Su, 2019, Vaccine.

Progress in vaccination towards hepatitis B control and elimination in the Region of the Americas

Marcela Contreras, S. Perez-Vilar, N. El Omeiri, 2017, BMC Public Health.

Adverse events reported to the U.S. Food and Drug Administration Adverse Event Reporting System for tisagenlecleucel

G. Dores, M. Niu, S. Perez-Vilar, 2021, American journal of hematology.

Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study

B. Carleton, M. Sturkenboom, S. Black, 2018, PloS one.

Cannabidiol exposures in the United States, National Poison Data System, July 2014–June 2021

S. Karami, S. Perez-Vilar, Kira Leishear, 2022, Clinical toxicology.

Effectiveness of rotavirus vaccines, licensed but not funded, against rotavirus hospitalizations in the Valencia Region, Spain

M. Martínez-Beneito, J. Díez-Domingo, S. Perez-Vilar, 2015, BMC Infectious Diseases.

Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration’s Adverse Event Reporting System, 2010-2017

G. Dores, S. Perez-Vilar, Marthe Bryant-Genevier, 2019, JAMA network open.

[Post-licensure passive safety surveillance of rotavirus vaccines: reporting sensitivity for intussusception].

J. Díez-Domingo, J. Puig-Barberá, S. Perez-Vilar, 2014 .

Safety Surveillance of Bivalent Meningococcal Group B Vaccine, Vaccine Adverse Event Reporting System, 2014-2018.

G. Dores, J. Duffy, John R Su, 2020, Open forum infectious diseases.

MF59™-adjuvanted seasonal influenza vaccine in young children

J. Díez-Domingo, J. Puig-Barberá, S. Perez-Vilar, 2011, Expert review of vaccines.

Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain

J. Díez-Domingo, S. Perez-Vilar, M. López-Lacort, 2017, BMC Infectious Diseases.

Influenza Vaccine Effectiveness in Preventing Influenza A(H3N2)-Related Hospitalizations in Adults Targeted for Vaccination by Type of Vaccine: A Hospital-Based Test-Negative Study, 2011–2012 A(H3N2) Predominant Influenza Season, Valencia, Spain

M. Tortajada-Girbés, A. Arnedo-Pena, V. Gil-Guillén, 2014, PloS one.

Population-based Analysis of Bronchiolitis Epidemiology in Valencia, Spain

J. Díez-Domingo, J. Puig-Barberá, S. Perez-Vilar, 2016, The Pediatric infectious disease journal.

Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study.

Alberto Arnedo-Pena, A. Arnedo-Pena, J. Puig-Barberá, 2010, Vaccine.

Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged ≥65 years, Vaccine Adverse Event reporting System (VAERS), United States, September 2010-December 2018.

G. Dores, P. Haber, M. Cano, 2019, Vaccine.

MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: comparative effectiveness using the Valencia health care information system.

J. Díez-Domingo, J. Calabuig-Pérez, J. Puig-Barberá, 2013, Vaccine.

Safety Surveillance of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccines

Paige W. Lewis, M. Cano, S. Perez-Vilar, 2018, Pediatrics.

Effectiveness of the 2010–2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: A case–case comparison, case-control study

A. Arnedo-Pena, V. Gil-Guillén, J. Díez-Domingo, 2012, Vaccine.

Case series of reports of pruritus and sipuleucel-T submitted to the Food and Drug Administration Adverse Event Reporting System

G. Dores, M. Niu, S. Perez-Vilar, 2019, Journal of Pharmaceutical Health Care and Sciences.